Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ultragenyx Pharmaceu (RARE)

Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ultragenyx Pharmaceu 60 Leveroni Court Novato CA 94949 USA

www.ultragenyx.com Employees: 1,276 P: 415-483-8800 F: 415-483-8810

Description:

Ultragenyx Pharmaceutical Inc. is focused on the identification, acquisition, development and commercialization of novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases.

Key Statistics

Overview:

Market Capitalization, $K 4,699,494
Enterprise Value, $K 4,485,914
Shares Outstanding, K 92,165
Annual Sales, $ 434,250 K
Annual Net Income, $ -606,640 K
Last Quarter Sales, $ 147,030 K
Last Quarter Net Income, $ -131,600 K
EBIT, $ -548,860 K
EBITDA, $ -535,700 K
60-Month Beta 0.58
% of Insider Shareholders 5.80%
% of Institutional Shareholders 97.67%
Float, K 86,819
% Float 94.20%
Short Volume Ratio 0.20

Growth:

1-Year Return 31.50%
3-Year Return -38.82%
5-Year Return 31.08%
5-Year Revenue Growth 743.20%
5-Year Earnings Growth -11.64%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.52 on 08/01/24
Next Earnings Date 11/05/24 [AMC]
Earnings Per Share ttm -7.30
EPS Growth vs. Prev Qtr 25.12%
EPS Growth vs. Prev Year 32.44%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

RARE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -266.02%
Return-on-Assets % -41.39%
Profit Margin % -139.70%
Debt/Equity 0.00
Price/Sales 10.82
Price/Cash Flow N/A
Price/Book 10.87
Book Value/Share 4.69
Interest Coverage -8.22
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar